Financial News
Latest News about CTLT
Recent news which mentions CTLT
   12 Health Care Stocks Moving In Monday's After-Market Session
   
  
  
  October 30, 2023
  From Benzinga
 
   The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
   
  
  
  October 24, 2023
  From MarketWatch
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  October 19, 2023
  From Benzinga
 
   Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
   
  
  
  October 09, 2023
  From Benzinga
 
   3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late
   
  
  
  September 07, 2023
  From InvestorPlace
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
   
  
  
  September 05, 2023
  From Benzinga
 
   Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny
   
  
  
  September 02, 2023
  From Benzinga
 
   Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count
   
  
  
  August 29, 2023
  From InvestorPlace
 
   Can a New CFO Save Canoo (GOEV) Stock?
   
  
  
  August 29, 2023
  From InvestorPlace
 
   ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?
   
  
  
  August 29, 2023
  From InvestorPlace
 From Benzinga
 
   Catalent (CTLT) Stock Gains on Elliott Deal
   
  
  
  August 29, 2023
  From InvestorPlace
 
   Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
   
  
  
  August 29, 2023
  From Benzinga
 
   Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
   
  
  
  August 25, 2023
  From Benzinga
 
   Why Novo Nordisk Stock Was Racing Higher on Wednesday
   
  
  
  August 23, 2023
  From Motley Fool
 
   One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
   
  
  
  August 23, 2023
  From Benzinga
 
   Why Is Regeneron Pharmaceuticals Moving Higher Today?
   
  
  
  August 03, 2023
  From Benzinga
 
   Novo Nordisk's Wegovy Supply Delays: FDA Uncovers Catalent Factory Lapses Violating Safety Regulations
   
  
  
  July 27, 2023
  From Benzinga
 
   As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
   
  
  
  July 21, 2023
  From MarketWatch
 From Benzinga
 From Benzinga
 From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
  
 
 
 










